Clinical Trials Browser

Hepatitis C × 1 year × Clear all

NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT05067374 2026-05-14

Mammo'C

Breast Neoplasms, Hepatitis C

NCT02366286 2026-04-24

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular

NCT01022476 2026-04-06

LIVERAL

Phase 1/2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

NCT01280825 2026-03-04

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Autoimmune Diseases, Blood Coagulation Disorders, Heart Diseases, Hepatitis C, Inflammatory Bowel Diseases

NCT04690972 2026-02-12

LivMOD

Gastrointestinal

Hepatitis D, Fibrosis, Hepatitis B, Hepatitis C, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Enrolling by invitation

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

NCT04525833 2025-09-19

Liver Disease and Other Systemic Diseases

15,000 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Diseases, Disease Progression, Carcinogenesis, Non-alcoholic Fatty Liver Disease

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT06842563 2025-07-09

Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

Active not recruiting

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

NCT07038863 2025-06-26

Mondelta

Phase NA Not yet recruiting

Gastrointestinal

Hepatitis D, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis